A pivotal study in 2014 reported that rat AFSC improved survival and enhanced repair of the damaged intestine in a preclinical rodent NEC model via a paracrine COX-2 (CycloOxygenase-2)-dependent mechanism by decreasing apoptosis and mucosal inflammation [48]. Here, PTGS2 is linked to necrotizing enterocolitis.